A trans-omics gene–smoking interaction study of lung cancer based on consortium data
American Journal of Respiratory and Critical Care Medicine · 2026
DOI: 10.1093/ajrccm/aamaf097 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory and Critical Care Medicine, 2026. Verfasst von Ning Xie und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Smoking, Gene-Environment Interaction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Science and Technology Major Project.
Abstract (Originalsprache)
Rationale
Genetically predicted molecular traits provide a cost-effective approach for identifying biomarkers and uncovering underlying biological mechanisms. We extended this framework to investigate gene–smoking interactions in lung cancer susceptibility.
Objectives
To identify trans-omics gene–smoking interactions affecting lung cancer risk and to assess how biomarkers modify effect of smoking.
Methods
We conducted the first trans-omics gene–smoking interaction study of lung cancer by integrating consortium-scale individual genotype data (27 737 cases vs 449 910 noncases) from the International Lung Cancer OncoArray Consortium (ILCCO-OncoArray), Transdisciplinary Research Into Cancer of the Lung (TRICL), Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), and the UK Biobank (UKB) with alliance-based summary-level molecular quantitative trait loci (xQTL) data, involving DNA methylation, gene expression, protein, and metabolite. Based on the identified biomarkers, we developed a molecular modifying score (MMS) to delineate gene–smoking interaction patterns and stratify smokers at high risk of lung cancer. Measurements and Main Results Eight biomarkers showing significant interactions with smoking were identified through a 2-phase analytic strategy, comprising CpG sites in the nicotinic acetylcholine receptor region and gene RP11-326C3.14. The MMS, constructed by integrating these biomarkers with their effect estimates derived from meta-analysis of all available datasets, effectively stratified lung cancer risk among smokers. Trans-omics integrative analysis revealed functional relationships across molecular layers, particularly implicating the NELFE gene in smoking-related carcinogenesis pathways.
Conclusions
The trans-omics association study (xWAS) framework enables systematic discovery of trans-omics gene–environment interactions. The MMS effectively delineates the patterns of the interaction effects and facilitates risk stratification. Additionally, we launched a free online platform, LungCancer-xWAS-GxE (http://bigdata.njmu.edu.cn/LungCancer-xWAS-GxE/).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China.
- Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing, China.
- Ministry of Education, Key Laboratory of Epidemiology of Major Diseases (Peking University), Beijing, China.
- Cancer Epigenetics Group, Josep Carreras Leukaemia Research Institute, Barcelona, Catalonia, Spain.
- Centro de Investigacion Biomedica en Red Cancer, Madrid, Spain.
- Institucio Catalana de Recerca i Estudis Avançats, Barcelona, Catalonia, Spain.
ORCID-Profile: Yongyue Wei, Zhibin Hu, Hongbing Shen, Yi Li, Feng Chen, Yang Zhao, Ruyang Zhang
Förderung
- NCI NIH HHS
- NIH HHS
- National Science and Technology Major Project
- Noncommunicable Chronic Diseases
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- NIEHS NIH HHS
- Outstanding Young Teachers Training Program of Nanjing Medical University
Zitieren
APA
Xie, N., Xu, X., Wang, Y., Wang, A., Wang, X., Wang, X., Zhao, M., Zhou, J., Wei, Y., Esteller, M., Hu, Z., Shen, H., Hung, R. J., Amos, C. I., Li, Y., Christiani, D. C., Chen, F., Zhao, Y., & Zhang, R. (2026). A trans-omics gene–smoking interaction study of lung cancer based on consortium data. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1093/ajrccm/aamaf097
Vancouver
Xie N, Xu X, Wang Y, Wang A, Wang X, Wang X, et al. A trans-omics gene–smoking interaction study of lung cancer based on consortium data. American Journal of Respiratory and Critical Care Medicine. 2026. doi:10.1093/ajrccm/aamaf097
BibTeX
@article{Xie2026,
author = {Xie, Ning and Xu, Xiaowen and Wang, Yanru and Wang, Aoxuan and Wang, Xiang and Wang, Xuan and Zhao, Mengsheng and Zhou, Jiacheng and Wei, Yongyue and Esteller, Manel and Hu, Zhibin and Shen, Hongbing and Hung, Rayjean J and Amos, Christopher I and Li, Yi and Christiani, David C and Chen, Feng and Zhao, Yang and Zhang, Ruyang},
title = {A trans-omics gene–smoking interaction study of lung cancer based on consortium data},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2026},
doi = {10.1093/ajrccm/aamaf097}
}
EUVIMED